Skip to main content
. 2011 Sep;105(6):447–453. doi: 10.1179/1364859411Y.0000000030

Table 2. Dosage of active ingredient and dissolution test of the sampled CQ tablets.

Active pharmaceutical ingredient Dissolution test
Countries Product no. API% RSD% Dissolution rate (%) RSD%
Benin Product 1 98.54 0.74 84.29 2.50
Product 2 93.16 1.86 56.60 9.10
Burkina Faso Product 3 96.26 2.72 78.04 4.09
Product 4 96.76 0.76 84.12 1.76
Product 5 81.88 2.20 75.69 2.63
Product 6 60.50 0.44 49.94 1.20
Product 7 94.73 2.52 68.71 1.98
Product 8 96.65 3.28 68.66 2.30
Product 9 150.81 0.71 86.11 0.93
Cameroon Product 10 97.05 1.04 71.83 5.31
Product 11 95.35 0.74 86.48 2.57
Product 12 94.27 1.02 77.32 1.97
Ivory Coast Product 13 99.48 0.49 82.74 2.69
Gabon Product 14 94.24 0.45 83.23 3.97
Product 15 97.72 1.45 84.04 2.90
Ghana Product 16 249.44 1.84 87.45 1.55
Comoros Product 17 102.50 3.90 73.42 1.92
Mali Product 18 94.86 1.49 78.34 3.62
Product 19 97.45 2.27 71.41 2.18
Product 20 93.97 0.64 66.17 1.85
Morocco Product 21 97.67 0.83 80.65 2.92
Niger Product 22 95.38 1.06 80.87 1.08
Product 23 100.68 1.17 84.81 3.01
Product 24 151.72 2.39 88.02 2.04
Senegal Product 25 97.36 1.19 78.49 9.00
Chad Product 26 97.00 1.18 83.80 2.81

RSD, relative standard deviation.